Hepatitis A
📧 Sign up to get email alerts when something new happens for Hepatitis A.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-04EMA Authorised: Twinrix Adult (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.
Twinrix Adult (hepatitis A virus inactivated + hepatitis B surface antigen) has been authorised for use in adults by the EMA.
-
EMA approval · 2026-08-03EMA Authorised: Twinrix Paediatric (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.
The EMA has authorised Twinrix Paediatric, a combined hepatitis A and B vaccine for children, under the marketing authorization holder Glaxo…
-
EMA approval · 2026-08-03EMA Authorised: Ambirix (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.
Ambirix, a vaccine containing inactivated hepatitis A virus and hepatitis B surface antigen, has been authorised for immunization against he…
-
EMA approval · 2024-02-08EMA Authorised: Ambirix (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.
Ambirix has been authorised for immunization against hepatitis A and hepatitis B infections.
-
EMA approval · 2024-02-07EMA Authorised: Twinrix Paediatric (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.
EMA authorised Twinrix Paediatric, a hepatitis A and hepatitis B combination vaccine for paediatric use.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2024-02-07EMA Authorised: Twinrix Adult (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.
Twinrix Adult has been authorised by the EMA for hepatitis A and hepatitis B immunization.